Munger-Jayne-23811-web

Jayne M. Munger

Associate
Full contact info

Experience

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, Boston
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Beam Announces Agreement for Lilly to Acquire Opt-In Rights to Verve Therapeutics’ Base-Editing Programs for Cardiovascular Disease

October 31, 2023

Cooley advised Beam Therapeutics, a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines, on its agreement with Verve Therapeutics to sell its opt-in rights to co-develop and co-commercialize base-editing programs for cardiovascular disease to Eli Lilly and Company.

Read more

Related contacts

Kenneth Krisko
Partner, Reston
Christophe Beauduin
Special Counsel, New York
Jiqiang Lin
Associate, New York
Jameson Davis
Associate, Boston
Eric Blanchard
Partner, Boston
Wouter Deleersnyder
Associate, New York
Jayne M. Munger
Associate, New York
Michael Tollini
Partner, Washington, DC
Matthew S. Scarano
Associate, San Diego
Matt Kong
Associate, San Francisco
Eileen Marshall
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
Marty Schenker
Senior Counsel , San Francisco
Michael McMahon
Partner, Boston

Related Practices & Industries

Pearl Health Closes $75 Million Series B Financing

January 26, 2023

Cooley represented Pearl Health, a technology company helping independent physician practices participate in value-based care models, on its $75 million oversubscribed Series B financing round, which was led by Andreessen Horowitz’s growth fund. Lawyers Roy Moran, Ariel Rom, Carly Goeman and Jayne Munger led the Cooley team advising Pearl Health.

Related contacts

Roy Moran
Partner, New York
Ariel Rom
Partner, New York
Carly J. Goeman
Associate, New York
Jayne M. Munger
Associate, New York

Related Practices & Industries

Runway Closes $50 Million Series C Financing

December 9, 2022

Cooley represented Runway, a developer of design tools made to bring the benefits of artificial intelligence to creative projects, on its $50 million Series C financing led by Felicis. Partner Sacha Ross led the Cooley team.

Related contacts

Sacha Ross
Partner, New York
Roy Moran
Partner, New York
Danielle Gershowitz
Partner, New York
Jayne M. Munger
Associate, New York
Katharina Schwarz
Associate, New York

Related Practices & Industries

Chainalysis Raises $170 Million in Series F, Doubles Valuation to $8.6 Billion

May 13, 2022

Cooley advised Chainalysis, a blockchain data platform, on its $170 million Series F preferred stock financing round, bringing its valuation to $8.6 billion – up from $4.2 billion following its Series E preferred stock financing round last year. Lawyers Andrew Gunther, Jodie Bourdet and Darwin Ng led the Cooley team advising Chainalysis.

Read more

Related contacts

Andrew Gunther
Associate, New York
Jodie Bourdet
Partner, San Francisco
Kevin King
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Bridget R. Reineking
Special Counsel, Washington, DC
Jayne M. Munger
Associate, New York
Karen Tsai
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Scott D. Rudin
Associate, New York
Dillon Martinson
Special Counsel, Washington, DC

Related Practices & Industries

View more

Admissions & credentials

New York